Kate R Oppegaard

8PUBLICATIONS
24CO-AUTHORS
Patient safetyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMemory and attention
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 17, 2026
Leveraging Smart Pump Event Log Data to Understand Medication Events: An Informaticist's Guide.

|Jun 02, 2026
Study Protocol to Characterize Symptom Experience During Immune Checkpoint Inhibitor Therapy for Cutaneous Melanoma.

|Nov 11, 2025
Cytokine-Cytokine Receptor Interaction and Endocytosis are Common Pathways for Symptom Burden and Sickness Behavior Symptoms in Oncology Patients Undergoing Chemotherapy.

Carolyn S Harris, Kord M Kober, Joosun Shin

|Sep 26, 2024
Self-reported cancer-related cognitive impairment is associated with perturbed neurotransmission pathways.

Kate R Oppegaard, Yvette P Conley, Steven Paul

|Apr 27, 2024
Neurodegenerative disease pathways are perturbed in patients with cancer who self-report cognitive changes and anxiety: A pathway impact analysis.

Kate R Oppegaard, Samantha J Mayo, Terri S Armstrong

|Apr 27, 2023
An Evaluation of the Multifactorial Model of Cancer-Related Cognitive Impairment.

Kate R Oppegaard, Samantha J Mayo, Terri S Armstrong

Pageof 2

Frequent Collaborators

7 joint publications

Christine Miaskowski

5 joint publications

Kord M Kober

5 joint publications

Yvette P Conley

5 joint publications

Jon D Levine